Regencell Bioscience Holdings (RGC) Valuation Update After Auditor Change To HTL International

Simply Wall St.04-27

AdvertisementAuditor change puts governance under the spotlight Regencell Bioscience Holdings (RGC) has replaced Marcum Asia CPAs LLP with HTL International, LLC as its independent registered public ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2630362747?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","is_english":true,"pubTime":"2026-04-27 16:05","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2630362747","market":"us","top_or_hot":-1,"title":"Regencell Bioscience Holdings (RGC) Valuation Update After Auditor Change To HTL International","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementAuditor change puts governance under the spotlight Regencell Bioscience Holdings (RGC) has replaced Marcum Asia CPAs LLP with HTL International, LLC as its independent registered public ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgc/regencell-bioscience-holdings/news/regencell-bioscience-holdings-rgc-valuation-update-after-aud\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regencell Bioscience Holdings (RGC) Valuation Update After Auditor Change To HTL International</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegencell Bioscience Holdings (RGC) Valuation Update After Auditor Change To HTL International\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-27 16:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgc/regencell-bioscience-holdings/news/regencell-bioscience-holdings-rgc-valuation-update-after-aud><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementAuditor change puts governance under the spotlight Regencell Bioscience Holdings (RGC) has replaced Marcum Asia CPAs LLP with HTL International, LLC as its independent registered public ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgc/regencell-bioscience-holdings/news/regencell-bioscience-holdings-rgc-valuation-update-after-aud\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RGC","symbol_name":"脑再生科技","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgc/regencell-bioscience-holdings/news/regencell-bioscience-holdings-rgc-valuation-update-after-aud","article_id":"2630362747","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-rgc/regencell-bioscience-holdings/news/regencell-bioscience-holdings-rgc-valuation-update-after-aud","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2630362747","pubTimestamp":1777277115,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Auditor change puts governance under the spotlight\nRegencell Bioscience Holdings (RGC) has replaced Marcum Asia CPAs LLP with HTL International, LLC as its independent registered public accounting firm, a governance move that can influence how investors view transparency and oversight.\nSee our latest analysis for Regencell Bioscience Holdings.\nThe latest auditor change lands after a strong year, with the share price at US$27.49 and a year to date share price return of 33.84%, while the 1 year...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"RGC":"脑再生科技","BK4539":"次新股","BK4007":"制药"},"translate_title":"审计师变更为HTL International后Regencell Bioscience Holdings(RGC)估值更新","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RGC":1.5},"content_text":"AdvertisementAuditor change puts governance under the spotlight Regencell Bioscience Holdings (RGC) has replaced Marcum Asia CPAs LLP with HTL International, LLC as its independent registered public accounting firm, a governance move that can influence how investors view transparency and oversight. See our latest analysis for Regencell Bioscience Holdings. The latest auditor change lands after a strong year, with the share price at US$27.49 and a year to date share price return of 33.84%, while the 1 year total shareholder return is extremely high. Recent 30 day share price gains, alongside weaker 90 day and 7 day returns, suggest momentum has cooled slightly as investors reassess risk and expectations around governance and future execution. If this kind of rapid move has you looking beyond a single name, it could be a good moment to broaden your search with 18 top founder-led companies With Regencell posting a 33.84% YTD gain but weaker 90 day and 7 day returns, and with zero revenue and ongoing losses, are you looking at an undervalued early stage story, or at a stock where the market is already pricing in future growth? Preferred price to book multiple of 2,796.9x, is it justified? Regencell Bioscience Holdings is trading on a P/B ratio of 2,796.9x, which stands out next to its last close at $27.49 and points to a very rich valuation compared to peers. The P/B ratio compares a company’s market value to its book value, essentially asking how many dollars investors are paying for each dollar of net assets. For a business with zero revenue and ongoing losses, such an elevated multiple usually reflects very high expectations about what those assets might produce in the future rather than what they are generating today. Against that backdrop, Regencell looks expensive both compared to the broader US Pharmaceuticals industry and to more closely matched peers. The industry average P/B is 2.6x and the peer average is 28.4x. The current 2,796.9x multiple is far above either reference point and suggests the market price is already assigning a very large premium to the company’s balance sheet and potential. See what the numbers say about this price — find out in our valuation breakdown. Result: Price to book ratio of 2,796.9x (OVERVALUED) However, you also have zero revenue, ongoing losses of US$3.58m and a very high P/B multiple, so any setback in clinical or regulatory progress could quickly hit sentiment. Find out about the key risks to this Regencell Bioscience Holdings narrative. Next Steps Concerned this all sounds stretched for a zero revenue, loss making business? If you want to move quickly and base your view on the available information, start by reviewing the 3 important warning signs Looking for more investment ideas? If this situation has sharpened your focus on risk and reward, it is a smart time to widen your watchlist with a few focused stock ideas.  Spot potential upside in quality names trading below what the numbers suggest by checking out 54 high quality undervalued stocks. Prioritise stability and support more consistent sleep at night by reviewing companies in the 73 resilient stocks with low risk scores. Explore opportunities before they become widely followed by scanning the screener containing 25 high quality undiscovered gems.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2630362747","isCrawlerRequest":true}